Chemical Works (RICHT.BD) Stock Analysis & Winston Score

Richter Gedeon (traded as RICHT on the Budapest Stock Exchange) is a Hungarian pharmaceutical company that makes and sells prescription medicines, over-the-counter drugs, and active pharmaceutical ingredients. Its most important products are in women's health, including contraceptives and hormone therapies, as well as treatments for central nervous system disorders. The company sells to hospitals, pharmacies, and healthcare systems across Europe, the United States, and many emerging markets. Richter earns money primarily by selling finished drug products and bulk pharmaceutical ingredients to distributors and healthcare providers. It operates mainly in Central and Eastern Europe but has a meaningful presence in Russia, the CIS region, and growing sales in the US through licensing partnerships. Its competitive edge comes from decades of expertise in female healthcare and a vertically integrated supply chain that keeps costs relatively low. The biggest risk the company faces is its significant exposure to Russia and neighboring markets, where geopolitical instability and currency swings can meaningfully hurt revenue.